As of June 06, 2026, Heron Therapeutics's top three insider holders are Capital Management Lp Rubric (TenPercentOwner, 30.05Mn shares), Adam Morgan (Director, 8.75Mn shares), Adam Morgan (Director, 6.99Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Stephen Davis | - | 52,032 | 0 | 20 Dec, 2022 |
| Kimberly Manhard | Evp, Drug Development | 28,330 | 0 | 17 Apr, 2023 |
| William P Forbes | Evp, Chief Development Officer | 185,647 | 0 | 21 Apr, 2026 |
| Craig A Collard | Chief Executive Officer | 662,052 | 0 | 21 Apr, 2026 |
| Craig A Johnson | - | 53,960 | 0 | 03 Feb, 2026 |
| Barry D Quart | Chief Executive Officer | 177,989 | 0 | 17 Jan, 2023 |
| Ira Duarte | Evp, Chief Financial Officer | 195,356 | 0 | 03 Feb, 2026 |
| Waage Christian | - | 53,960 | 0 | 03 Feb, 2026 |
| David Leslie Szekeres | Evp, Chief Operating Officer | 33,754 | 0 | 17 Jul, 2023 |
| Capital Management Lp Rubric | - | 0 | 30,046,828 | 17 Oct, 2025 |
| Lisa Peraza | Vp, Chief Accounting Officer | 55,907 | 0 | 16 Jan, 2024 |
| Sharmila Dissanaike | - | 53,960 | 0 | 03 Feb, 2026 |
| Adam Morgan | - | 0 | 8,753,290 | 12 Aug, 2025 |
| Thomas Cusack | - | 53,960 | 0 | 03 Feb, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 19 Apr, 2026 | William P Forbes | Common Stock | A | 3,874 | - | 185,647 | D | M |
| 19 Apr, 2026 | Craig A Collard | Common Stock | A | 13,797 | - | 662,052 | D | M |
| 19 Apr, 2026 | William P Forbes | Restricted Stock Units | D | 3,874 | $0.00 | 27,120 | D | M |
| 19 Apr, 2026 | Craig A Collard | Restricted Stock Units | D | 13,797 | $0.00 | 96,758 | D | M |
| 03 Apr, 2026 | Craig A Collard | Common Stock | A | 62,500 | - | 648,255 | D | M |
| 03 Apr, 2026 | Craig A Collard | Restricted Stock Units | D | 62,500 | $0.00 | 62,500 | D | M |
| 30 Jan, 2026 | Sharmila Dissanaike | Common Stock | A | 53,960 | $0.00 | 53,960 | D | A |
| 30 Jan, 2026 | William P Forbes | Restricted Stock Units | A | 188,315 | $0.00 | 188,315 | D | A |
| 30 Jan, 2026 | Adam Morgan | Common Stock | A | 53,960 | $0.00 | 123,737 | D | A |
| 30 Jan, 2026 | Mark Earl Hensley | Restricted Stock Units | A | 188,315 | $0.00 | 188,315 | D | A |
| 30 Jan, 2026 | Adam Morgan | Common Stock | A | 53,960 | $0.00 | 123,737 | D | A |
| 30 Jan, 2026 | Craig A Collard | Restricted Stock Units | A | 800,337 | $0.00 | 800,337 | D | A |
| 30 Jan, 2026 | Craig A Johnson | Common Stock | A | 53,960 | $0.00 | 53,960 | D | A |
| 30 Jan, 2026 | Mark Earl Hensley | Restricted Stock Units | A | 188,315 | $0.00 | 188,315 | D | A |
| 30 Jan, 2026 | Adam Morgan | Common Stock | A | 53,960 | $0.00 | 123,737 | D | A |
| 30 Jan, 2026 | Mark Earl Hensley | Restricted Stock Units | A | 188,315 | $0.00 | 188,315 | D | A |
| 31 Jan, 2026 | Craig A Collard | Common Stock | A | 34,789 | - | 571,710 | D | M |
| 30 Jan, 2026 | Mark Earl Hensley | Restricted Stock Units | A | 188,315 | $0.00 | 188,315 | D | A |
| 30 Jan, 2026 | Adam Morgan | Common Stock | A | 53,960 | $0.00 | 123,737 | D | A |
| 31 Jan, 2026 | William P Forbes | Common Stock | A | 11,695 | - | 181,773 | D | M |